Tempest Therapeutics, Inc.
Pharmaceutical company · Brisbane, California, United States · Nasdaq: TPST
Tempest Therapeutics, Inc. is a pharmaceutical company headquartered in Brisbane, California, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker TPST. It has reported private securities offerings to the US SEC, most recently $4.1 million sold in a notice filed in 2026.
What does Tempest Therapeutics do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $4.1 million sold (2026).
Frequently asked questions about Tempest Therapeutics
Where is Tempest Therapeutics headquartered?
Tempest Therapeutics, Inc. is headquartered in Brisbane, California, United States.
What does Tempest Therapeutics do?
Tempest Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Tempest Therapeutics a public company?
Yes. Tempest Therapeutics, Inc. trades on Nasdaq under the ticker TPST.
When was Tempest Therapeutics founded?
The earliest incorporation on record for Tempest Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Annexon, Inc.Brisbane, California, United States
- Day One Biopharmaceuticals, Inc.Brisbane, California, United States
- Vera Therapeutics, Inc.Brisbane, California, United States
- Aimmune Therapeutics, Inc.Brisbane, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.